They are regularly reviewed, because it's a joint project with the provinces and territories and the experts in the area. So they do get periodically reviewed, and that will continue. There are always surprises, but that's also why, for example, in the middle of an outbreak, something we've never seen before, we develop a case definition that day as a working definition, so all jurisdictions can do it, so we know what we're looking for. This is not an infectious disease issue, but with melamine and the children, through our surveillance system that we operate with the Canadian Paediatric Society, they were able to contact all the pediatricians in the country looking for these symptoms and to see if in fact there was any impact in Canada of that from a syndromic surveillance standpoint, before we even knew there was melamine in baby formula in Canada.
That's the kind of stuff we have to do. In all these things there is no disagreement between us and the Auditor General in terms of importance of these things. We will do that. It does take time. I can't speak for the previous two audits. This is the first one I've dealt with. We've made significant progress since the beginning of the agency. We will continue to do it, so when you come back to this again I'm sure you will be happy, for lack of a better term.